Figure 6.
Characterization of cancellous bone microarchitecture by μCT analysis during HT treatment. Analysis shown was performed in lumbar vertebrae. A. Prevention of cancellous bone loss in WT mice in BV/TV, Tb.N. and Tb.Sp. (n = 9–13). B. Similar prevention of cancellous bone loss in AR2.3-tg mice by immediate DHT treatment (n = 11–15). C. Immediate DHT treatment for prevention of cancellous bone loss in AR3.6-tg mice (n = 12–15). All data expressed as mean ± SEM. * p < 0.05, *** p < 0.001 vs. sham controls; ### p < 0.001 vs. ORX; + p < 0.05, ++ p < 0.01, +++ p < 0.001 vs. WT sham.